A new joint statement from the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) provides clinicians updated guidance on the use of systemic and non-biologic medications for the treatment of psoriasis.

The guideline was published in the Journal of the American Academy of Dermatology.